Literature DB >> 21181097

[Coronary artery disease in HIV-infected subjects. Results of 101 coronary angiographies].

T Neumann1, K A Lülsdorf, P Krings, N Reinsch, R Erbel.   

Abstract

BACKGROUND: The introduction of antiretroviral therapy has brought cardiac disease as a comorbidity in HIV-infected patients in particular into focus. The present study analyses the results of coronary angiography in this patient population.
METHODS: Over a time period of 12 years, 101 coronary angiographies were performed in HIV-infected patients. A retrospective analysis included demographic parameters, cardiac history, cardiovascular risk factors, HIV-specific parameters including antiretroviral therapy and the results of coronary angiographies.
RESULTS: Of the subjects included in the study, 89% were men. The mean age in the analysed population was 50.2 years at the time of coronary angiography. Patients had an elevated rate of cardiovascular risk factors including diabetes mellitus (15.9%), arterial hypertension (65.9%), hyperlipidemia (56.8 %) and smoking (68.2 %). Primary coronary angiography demonstrated coronary disease in 59.1%. Of all patients with coronary artery disease, 70% underwent coronary intervention. Subjects who underwent coronary intervention exhibited hyperlipidemia significantly more often (77.8% vs. 42.3%, p=0.02). Cardiovascular risk factors play a prominent role in the development of premature arteriosclerosis in HIV-infected patients. Furthermore, our data highlight the importance of invasive diagnostics in this patient group.

Entities:  

Mesh:

Year:  2010        PMID: 21181097     DOI: 10.1007/s00059-010-3410-7

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  21 in total

1.  Cardiovascular risk factors and probability for cardiovascular events in HIV-infected patients. Part II: gender differences.

Authors:  Till Neumann; T Woiwod; A Neumann; B Ross; C Von Birgelen; L Volbracht; Norbert H Brockmeyer; G Gerken; R Erbel
Journal:  Eur J Med Res       Date:  2004-02-27       Impact factor: 2.175

Review 2.  [Premature arteriosclerosis in HIV-infected patients? Current status].

Authors:  Christian Hoffmann
Journal:  Herz       Date:  2005-09       Impact factor: 1.443

3.  [Metabolic syndrome and hyperlipidemia in HIV-positive patients].

Authors:  Georg M N Behrens
Journal:  Herz       Date:  2005-09       Impact factor: 1.443

Review 4.  [Cardiac manifestations in HIV-infected individual].

Authors:  Till Neumann; Birgit Ross; Ulrich R Hengge; Guido Gerken; Raimund Erbel
Journal:  Med Klin (Munich)       Date:  2002-11-15

5.  Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients.

Authors:  Bela F Asztalos; Ernst J Schaefer; Katalin V Horvath; Caitlin E Cox; Sally Skinner; Jul Gerrior; Sherwood L Gorbach; Christine Wanke
Journal:  Atherosclerosis       Date:  2005-06-01       Impact factor: 5.162

6.  Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.

Authors:  U H Iloeje; Y Yuan; G L'italien; J Mauskopf; S D Holmberg; A C Moorman; K C Wood; R D Moore
Journal:  HIV Med       Date:  2005-01       Impact factor: 3.180

7.  Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection.

Authors:  Samuel A Bozzette; Christopher F Ake; Henry K Tam; Sophia W Chang; Thomas A Louis
Journal:  N Engl J Med       Date:  2003-02-20       Impact factor: 91.245

8.  Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study.

Authors:  Till Neumann; Stefan Esser; Anja Potthoff; Sabine Pankuweit; Anja Neumann; Frank Breuckmann; Katrin Neuhaus; Jana Kondratieva; Thomas Buck; Thomas Müller-Tasch; Rolf Wachter; Christiane Prettin; Götz Gelbrich; Wolfgang Herzog; Burkert Pieske; Mathias Rauchhaus; Markus Löffler; Bernhard Maisch; Andreas Mügge; Jürgen Wasem; Guido Gerken; Norbert H Brockmeyer; Raimund Erbel
Journal:  Eur J Med Res       Date:  2007-06-27       Impact factor: 2.175

9.  Class of antiretroviral drugs and the risk of myocardial infarction.

Authors:  Nina Friis-Møller; Peter Reiss; Caroline A Sabin; Rainer Weber; Antonella d'Arminio Monforte; Wafaa El-Sadr; Rodolphe Thiébaut; Stephane De Wit; Ole Kirk; Eric Fontas; Matthew G Law; Andrew Phillips; Jens D Lundgren
Journal:  N Engl J Med       Date:  2007-04-26       Impact factor: 91.245

10.  Clinical features of acute coronary syndromes in patients with human immunodeficiency virus infection.

Authors:  Priscilla Y Hsue; Kamini Giri; Sara Erickson; John S MacGregor; Naji Younes; Amandeep Shergill; David D Waters
Journal:  Circulation       Date:  2004-01-12       Impact factor: 29.690

View more
  2 in total

Review 1.  Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.

Authors:  Craig Sturgeon; Alessio Fasano
Journal:  Tissue Barriers       Date:  2016-10-21

Review 2.  Infectious and coronary artery disease.

Authors:  Mohammad Saeid Rezaee-Zavareh; Mohammad Tohidi; Amin Sabouri; Mahdi Ramezani-Binabaj; Mohsen Sadeghi-Ghahrodi; Behzad Einollahi
Journal:  ARYA Atheroscler       Date:  2016-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.